SaiamaNaheedWaqarMD

Clinical Trials

• MTD Study PXD-101 in Combination With Paclitaxel + Carboplatin in Chemotherapy-Naive Patients With Stage IV NSCLC Start of enrollment: 2010 Dec 01

  Completed

  Phase 1, Phase 2

• Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2012 Apr 01

  Terminated

  Phase 2, Phase 3

• Megestrol Acetate With or Without Mirtazapine in Treating Cancer Patients With Weight Loss or Loss of Appetite Start of enrollment: 2013 Sep 01

  Withdrawn

  Phase 2

• Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer Start of enrollment: 2012 Jun 01

  Completed

  Phase 1, Phase 2

• Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer Start of enrollment: 2012 Jun 01

  Completed

  Phase 2

• Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies Start of enrollment: 2013 May 07

  Completed

  Phase 1

• Response to Influenza Vaccine in Patients With Non-Hematologic Malignancies Receiving Chemotherapy Start of enrollment: 2011 Sep 01

  Terminated

  Phase 1

• VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors Start of enrollment: 2013 May 03

  Terminated

  Phase 1, Phase 2

• Hypofractionated Proton Beam Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Stage II-III Non-Small Cell Lung Cancer Start of enrollment: 2014 May 22

  Completed

  Phase 1

• Pazopanib in Molecularly Selected Patients With Advanced NSCLC Start of enrollment: 2015 Apr 27

  Terminated

  Phase 2

• Falls Risk Questionnaire in Older Adults With Cancer Start of enrollment: 2014 Aug 01

  Completed

• Phase I Study of Pyrotinib in Patients With HER2-positive Solid Tumors Start of enrollment: 2015 Jun 01

  Active, not recruiting

  Phase 1

• Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors Start of enrollment: 2015 Dec 01

  Withdrawn

  Phase 1

• Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) Start of enrollment: 2015 Nov 19

  Active, not recruiting

  Phase 2

• Rociletinib Genomic Landscape in Non-small Cell Lung Cancer (NSCLC) Start of enrollment: 2016 May 01

  Withdrawn

  Phase 2

• Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors Start of enrollment: 2016 Sep 23

  Terminated

  Phase 1, Phase 2

• A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer Start of enrollment: 2016 May 11

  Completed

  Phase 2

• eXalt3: Study Comparing X-396 (Ensartinib) to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients Start of enrollment: 2016 Jun 01

  Active, not recruiting

  Phase 3

• Optimizing Fall-risk Prediction in Older Adults With Cancer Start of enrollment: 2016 Oct 12

  Completed

• Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC Start of enrollment: 2017 Jun 29

  Terminated

  Phase 2

• Join now to see all